Physician profile
Brook Choulet
NPI 1083146807
$2,249.40
in general payments reported to CMS, 2019-2025
19 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $462 · 2021: $736 · 2022: $260 · 2023: $173 · 2024: $289 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $670.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $283.97 | 2021-2025 | Spravato |
| Takeda Pharmaceuticals U.S.A., INC. | $247.17 | 2021-2025 | Trintellix |
| Alexion Pharmaceuticals, INC. | $235.06 | 2019-2020 | |
| Corium, LLC | $226.34 | 2022 | |
| Abbvie INC. | $210.85 | 2021-2024 | Vraylar |
| Vifor Pharma, INC. | $165.43 | 2020-2021 | |
| Lundbeck LLC | $164.13 | 2023-2024 | Rexulti |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $140.44 | 2020 | |
| Tris Pharma INC | $132.39 | 2021 | |
| Portola Pharmaceuticals, LLC | $115.90 | 2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $67.71 | 2024-2025 | Caplyta |
| Jazz Pharmaceuticals INC. | $60.59 | 2024 | |
| Sk Life Science, INC. | $49.82 | 2021 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $44.05 | 2025 | Rejoyn |
| Allergan, INC. | $41.89 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noven Therapeutics, LLC | $19.00 | 2025 | Xelstrym |
| Almatica Pharma LLC | $16.06 | 2024 | Loreev Xr |
| Vanda Pharmaceuticals INC. | $15.50 | 2022 | |
| Neuronetics, INC. | $13.10 | 2023 | Neurostar Tms Therapy System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brook Choulet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.